Effect of Clinical Crown Lengthening Surgery and Botulinum Toxin A Injection in Gummy Smile Treatment
Study Details
Study Description
Brief Summary
Background: The demand for beauty is increasing in society as everyone is looking for cosmetic improvement, including gummy smile correction.
Object: This study aims to evaluate the efficacy of a combination of a clinical tooth crowns lengthening surgery following by a BTX-A injection in gummy smile treatment upon based on clinical assessment and photography
Method: An uncontrolled longitudinal study was implemented at the Faculty of Odonto-Stomatology (FOS) of the University of Medicine and Pharmacy at Ho Chi Minh City (UMPH), Viet Nam, from August 2020 to May 2021. Twenty patients (19 females and one male) at a mean age of 24 years old who came for gummy smile chief complaint were included in the study. Subjects were operated to lengthen the clinical crown following an additional botulinum toxin A injection two months post-surgery. All the participants answered the smile esthetic satisfactory questions and were photographed at the time before treatment (T0), two months after clinical crown lengthening surgery (T1), two weeks (T2), and two months (T3) follow-up visits after BTX-A injection. The gingival exposure (GE) and clinical crown length (CCL) were measured at each time point for analysis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Subjects with gummy smile The study procedure consisted of recruitment, pre&post-operative photography, gingivoplasty, BTX-A injection, recall visits, and data collecting. |
Procedure: Clinical crown lengthening surgery
Clinical dental crown lengthening surgery protocol: a clinical crown lengthening surgery was performed.
Post-operation protocol Patients were all prescribed antibiotics , anti-inflammation, analgesic, and an antiseptic mouthwash. Patients were instructed for oral hygiene and recalls.
Botulinum Toxin A injection One hundred units (U) of botulinum toxin A (BTX-A) were diluted with 2.5ml of sterile saline solution without shaking. 1 mm syringe with a 30-gauge needle was used to get 0.25ml BTX-A for four-point injection, or 0.6ml in case injection of 6 points. Cold compress was applied extraoral 5 mins at injection site before injection.
After local anesthesia, the doctor administered slowly 2,5 U of diluted BTX-A at each point until white cellulite appeared.
Patients were recalled two weeks (T2), and two months (T3) after injection.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Gingival exposure [At the time before treatment (T0)]
The outcome is measured in millimeters based on photos of subjects included
- Gingival exposure [Two months after clinical crown lengthening surgery (T1)]
The outcome is measured in millimeters based on photos of subjects included
- Gingival exposure [Two weeks after Botulinum toxin A injection (T2)]
The outcome is measured in millimeters based on photos of subjects included
- Gingival exposure [Two months after Botulinum toxin A injection (T2)]
The outcome is measured in millimeters based on photos of subjects included
- Clinical crown length [At the time before treatment (T0)]
The clinical crown length is measured in millimeters using digital caliper and periodontal probe
- Clinical crown length [Two months after clinical crown lengthening surgery (T1)]
The clinical crown length is measured in millimeters using digital caliper and periodontal probe
- Clinical crown length [Two weeks after Botulinum toxin A injection (T2)]
The clinical crown length is measured in millimeters using digital caliper and periodontal probe
- Clinical crown length [Two months after Botulinum toxin A injection (T2)]
The clinical crown length is measured in millimeters using digital caliper and periodontal probe
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Gummy smile because of 2 combined etiologies:
-
Short clinical crown of teeth due to the altered passive tooth eruption
-
Hyperactivity of upper lip muscles (lip mobility level > 8mm)
Exclusion Criteria:
-
Pregnant or breastfeeding patients
-
Gummy smiles due to:
-
Maxillary bone overgrowth (maxillary hypertrophy)
-
Vertical maxillary excess
-
Neuromuscular disorder
-
Gingival hyperplasia due to medicine, supplements, or neuromuscular transmission inhibiting agents
-
Systematic diseases that can affect the result of surgical treatment (such as diabetes, heart disease taking blood anticoagulant medicament, blood diseases, immunodeficiency disease etc.)
-
Allergy to BTX-A or albumin
-
History of taking BTX-A injection in the head-neck area formerly
-
Patient with any contraindication of surgery
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Faculty of Odontostomatology - University of Medicine and Pharmacy at Ho Chi Minh City | Ho Chi Minh City | Vietnam | 749000 |
Sponsors and Collaborators
- University of Medicine and Pharmacy at Ho Chi Minh City
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 20338-DHYD